Delivery Order SPE2DB22D3501-SPE2DB24FXC24
Award Date
9/25/24
Potential Completion Date
10/17/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $116,823.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, and has an ultimate completion date of January 9, 2024. The contract is a firm fixed-price arrangement, and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, with an identifier of SPE2DB22D2206|SPE2DB25FDZ51, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $24,999.30 Firm Fixed Price Delivery Order is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award, valued at $18,479.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 20 MG VIALS, a pharmaceutical product, with a completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FEA02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price, is for the supply of PADCEV 30 MG VIALS, a medical product. The contract has an ultimate completion date of November 28, 2023 and a ceiling value of $19,470.64. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,999.72 firm fixed-price delivery order is for the supply of PADCEV 30 MG vials, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical....
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY1FS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,771.90 firm fixed-price delivery order is for the supply of 30mg vials of the drug PADCEV, with a period of performance ending on March 31, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FUZ83, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $6,659.28 firm fixed price delivery order is for the supply of PADCEV 20 MG vials, a pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA valued up to...
This federal contract award, valued at $14,999.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product PADCEV 30 MG VIALS and has a completion date of June 11, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is delivering these items without any set-aside designation. This contract is associated with a...
This federal contract award, with a ceiling value of $14,602.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not designated under any set-aside program. Amerisourcebergen is the...